MedTrace Logo

Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01933321 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-04-03

No results posted yet for this study

Summary

Autologous cell therapy in patients with ALS can stimulate neuroplasticity, modifying the neurodegenerative process and stops the clinical progression of disease.

Conditions

Interventions

BIOLOGICAL

Intrathecal autologous stem cell

Mobilization and collection of stem cells for intravenous and intrathecal administration

Sponsors & Collaborators

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • David Gomez-Almaguer, MD · Hospital Universitario "Dr. José Eleuterio González"

  • Jose C Jaime-Pérez, MD PhD · Hospital Universitario "Dr. José Eleuterio González"

  • Héctor R Martínez-Rodríguez, MD PhD · Hospital Universitario "Dr. José Eleuterio González"

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-01-31
Completion
2014-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01933321 on ClinicalTrials.gov